Healthcare Wire Hong Kong
SEE OTHER BRANDS

Your health and wellness news from Hong Kong

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Wire Hong Kong.

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S., Europe, and Japan; and Pioneer Drug Designation in Japan for Stargardt disease Last subject...

EX.IO and CTI Capital Partner to Issue Hong Kong's First Convertible Promissory Note RWA, Defining a New Era for Digital Asset Finance

EX.IO and CTI Capital Partner to Issue Hong Kong's First Convertible Promissory Note RWA, Defining a New Era for Digital Asset Finance

HONG KONG, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Global Web3 innovation group EXIO Group Limited (hereinafter "EX.IO") and the licensed trustee subsidiary of Capital Management Limited (hereinafter "CTI Capital") as the wholly-owned overseas platform...

Complementary and Alternative Medicine Market is the focus of a groundbreaking new report by Maximize Market Research

Complementary and Alternative Medicine Market is the focus of a groundbreaking new report by Maximize Market Research

Complementary and Alternative Medicine revenue is expected to grow at a CAGR of 17.9% from 2025 to 2032, reaching nearly USD 504.52 Billion WILMINGTON, DE, UNITED STATES, September 11, 2025 /⁨EINPresswire.com⁩/ -- Maximize Market Research recently...

Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection

Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection

Hong Kong, Sept. 09, 2025 (GLOBE NEWSWIRE) -- With Hong Kong’s aging population, Alzheimer’s disease has become a major public health challenge. The Hong Kong Council of Social Service projects that by 2036, the number of people with dementia in...

INFLO to Join 2025 K-Tourism Roadshow in Hong Kong, Accelerating Global Expansion as a K-Medical Beauty Platform.

INFLO to Join 2025 K-Tourism Roadshow in Hong Kong, Accelerating Global Expansion as a K-Medical Beauty Platform.

Up to 49% discount benefits offered… Operating a B2C booth for local consumers with direct reservations for Korea’s plastic surgery and dermatology procedures. SEOUL, SOUTH KOREA, September 1, 2025 /⁨EINPresswire.com⁩/ -- INFLO, a specialized...

Asian Health & Beauty Leader NutriWorks™ Joins 2025 Emmys Week with Innovative Reflexology Foot Patches

Asian Health & Beauty Leader NutriWorks™ Joins 2025 Emmys Week with Innovative Reflexology Foot Patches

BOCA RATON, FL, UNITED STATES, September 8, 2025 /⁨EINPresswire.com⁩/ -- Following multiple national and international product launches, as well as an upcoming appearance at the ECRM Vitamin, Weight Management & Sports Nutrition Session, Asian...

Gynecological Devices Market Size Soars USD 25.36 Billion by 2034 | Towards Healthcare

Gynecological Devices Market Size Soars USD 25.36 Billion by 2034 | Towards Healthcare

Ottawa, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The global gynecological devices market size was estimated at USD 11.03 billion in 2024 and is expected to grow to USD 25.36 billion by 2034, registering a CAGR of 8.68%, according to a study by Towards...

WOW Summit 2025 Returns to Hong Kong, Uniting Global Tech Titans to Shape the Future of Web3 and AI

WOW Summit 2025 Returns to Hong Kong, Uniting Global Tech Titans to Shape the Future of Web3 and AI

HONG KONG, Aug. 27, 2025 (GLOBE NEWSWIRE) -- WOW Summit, Asia's premier gathering of technology & innovation, will make its return to Hong Kong in the year 2025. Supported by the Government of Hong Kong (SAR), Invest Hong Kong, and the Hong Kong...

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...

CorVista Health Announces Publication of Real-World Case Series in the Journal of the American College of Cardiology Exploring its Non-Invasive Test for Earlier Diagnosis of Pulmonary Hypertension

CorVista Health Announces Publication of Real-World Case Series in the Journal of the American College of Cardiology Exploring its Non-Invasive Test for Earlier Diagnosis of Pulmonary Hypertension

BETHESDA, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced the publication of a new case series in the Journal of the American College of Cardiology (JACC), showcasing real-world clinical applications of the CorVista...

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth...

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

- Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease - - Additional $150 million associated with the upcoming results of the obexelimab Phase 3 INDIGO trial and FDA approval for...

UM hosts Guangdong-Hong Kong-Macao Greater Bay Area Interdisciplinary Doctoral Forum

UM hosts Guangdong-Hong Kong-Macao Greater Bay Area Interdisciplinary Doctoral Forum

MACAU, August 22 - The Institute of Advanced Studies in Humanities and Social Sciences (IAS) at the University of Macau (UM) held the 3rd Guangdong-Hong Kong-Macao Greater Bay Area Interdisciplinary Doctoral Forum. The two-day forum brought...

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries ROME, ITALY, September 2, 2025 /⁨EINPresswire.com⁩/ -- SeqOne, a pioneer in AI-driven genomic...

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries BERLIN, GERMANY, September 2, 2025 /⁨EINPresswire.com⁩/ -- SeqOne, a pioneer in AI-driven genomic...

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries MADRID, SPAIN, September 2, 2025 /⁨EINPresswire.com⁩/ -- SeqOne, a pioneer in AI-driven genomic...

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million

Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease Additional $150 million associated with the upcoming results of the obexelimab Phase 3 INDIGO trial and FDA approval for the...

IAM and Ocean Park Hong Kong sign memorandum of intent for conservation cooperation

IAM and Ocean Park Hong Kong sign memorandum of intent for conservation cooperation

MACAU, August 21 - The delegation of the representatives of Ocean Park Hong Kong visited the Municipal Affairs Bureau (IAM) today (21 August). Both parties signed the “Memorandum of Intent for Conservation Cooperation between Municipal Affairs...

China: ICRC attends the 50th Florence Nightingale Medal Award Ceremony

China: ICRC attends the 50th Florence Nightingale Medal Award Ceremony

Your Excellencies, Distinguished Awardees of the Florence Nightingale Medal, Ladies and gentlemen, On behalf of the International Committee of the Red Cross, I am delighted to attend the Award Ceremony of the Florence Nightingale Medal today. The...

Studycat Head of Learning Jake Whiddon appointed Education Advisor to WAH Foundation

Studycat Head of Learning Jake Whiddon appointed Education Advisor to WAH Foundation

Partnership expands access to quality language learning programs in rural Cambodia through proven educational technology HONG KONG, HONG KONG, September 12, 2025 /⁨EINPresswire.com⁩/ -- Studycat announces that Jake Whiddon, Head of Learning, has...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions